At Massachusetts General Hospital, translational research is the engine that moves science discoveries from the laboratory to the hospital bed and back again.
Translational research pairs basic scientists with clinicians to identify discoveries that have promising medical applications.
Translational research is the engine that moves science from the laboratory bench to the hospital bed and back again.
Our translational research team works closely with basic scientists to identify new discoveries that have promising medical applications.
The team then connects those scientists with the resources they need to take the next step in developing new treatments, diagnostics and devices.
This could include connecting the scientist with an industry partner, arranging a licensing agreement or technology transfer, or forming a multidisciplinary team to conduct preclinical research.
Translational research also operates in the reverse direction, taking new medical insights that develop during clinical trials and feeding them back to the laboratory for further investigation by our scientists.A Uniquely Productive Setting
Massachusetts General Hospital provides a uniquely productive setting for translational research by pairing a vast basic research division with one of the top clinical hospitals in the country. This provides excellent opportunities for cross-disciplinary collaboration.
Here are just a few examples:
- Vaccine and Immunotherapy Center (VIC) VIC works with medical and business professionals to develop the most promising cancer and infectious disease vaccines and immunotherapies. Visit the VIC website
- Psychiatry Clinical Trials Network and Institute (CTNI)The CTNI connects industry sponsors to researchers who are experts in areas of psychiatric research including anxiety, depression, bipolar disorders, women's mental health, schizophrenia, geriatrics, Alzheimer's disease and more. Visit the CTNI website
- Neurological Clinical Research Institute (NCRI)The NCRI supports research in many neurotherapuetic areas, including Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, spinal muscular atrophy, stroke, multiple sclerosis, Parkinson's disease and Duchene Muscular Dystrophy, among others. Visit the NCRI website.
Invitation to Industry
Partnerships between industry and medical academia have emerged as a key component in bridging the gap between basic science and clinical applications. Industry members are invited to collaborate with us as we continue to push the boundaries of science and medicine to improve patient care.
Your gift helps fund groundbreaking research aimed at understanding, treating and preventing human disease.
Enroll in RSVP for Health, Mass General's Research Study Volunteer Program, to receive information about new clinical research studies related to your medical condition.